| 000 | 01705 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517113555.0 | ||
| 264 | 0 | _c20180205 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1432-1920 | ||
| 024 | 7 |
_a10.1007/s00234-016-1740-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpampinato, M V | |
| 245 | 0 | 0 |
_aGender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease. _h[electronic resource] |
| 260 |
_bNeuroradiology _cNov 2016 |
||
| 300 |
_a1143-1151 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlzheimer Disease _xepidemiology |
| 650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
| 650 | 0 | 4 |
_aAtrophy _xepidemiology |
| 650 | 0 | 4 | _aCausality |
| 650 | 0 | 4 |
_aCognitive Dysfunction _xepidemiology |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEntorhinal Cortex _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGenetic Predisposition to Disease _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Distribution |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aLangdon, B R | |
| 700 | 1 | _aPatrick, K E | |
| 700 | 1 | _aParker, R O | |
| 700 | 1 | _aCollins, H | |
| 700 | 1 | _aPravata', E | |
| 773 | 0 |
_tNeuroradiology _gvol. 58 _gno. 11 _gp. 1143-1151 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00234-016-1740-8 _zAvailable from publisher's website |
| 999 |
_c26386280 _d26386280 |
||